Antibiotics: Market Analysis & Business Opportunities

Antibiotics, also called antibacterials or antimicrobials, is a group of medicines used in the treatment of infections caused by germs—bacteria and certain parasites—by inhibiting the growth of microorganisms or killing them. Since the discovery of the antibiotic penicillin in 1920, various antibiotic compounds have been widely used to treat several bacterial infections. Increasing incidence of chronic and infectious diseases across the globe and efficacy of antibiotics to treat a wide spectrum of bacterial infections have led to the rapid evolution of the global antibiotic market. Based on geography, the report segments the global antibiotic markets into North America, Europe, Asia Pacific, and Rest of the World (ROW). Currently, Asia Pacific accounts for the leading share in the global antibiotic market. The region is likely to present exciting growth opportunities along the forecast period, driven by the prevalence of various infectious diseases, favorable regulatory reforms, and significant demand for generic medicines. A large number of players have been actively focusing on new drug development and clinical trials. Prominent biotechnology companies are entering into strategic alliances, which has helped them make considerable investments in drug discovery. Pharmaceutical companies are actively developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Key players operating in the global antibiotic market include Pfizer Inc., Astellas Pharma, Inc, Roche, Novartis AG, Bristol-Myers Squibb Co., Bayer HealthCare AG, Abbott Laboratories, MiddleBrook Pharmaceuticals, Takeda Pharmaceutical Company, Ltd., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Eli Lilly and Co., and Kyorin Pharmaceutical Co., Ltd. The antibiotics market was valued at USD 39.8 billion in 2015 and is expected to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products. According to the data published by the Pew Charitable Trust, in March 2016, about 37 promising molecules were being investigated within the U.S. market. Majority of these, are in phase II clinical trials and are anticipated to hit the market between 2018 - 2020. Furthermore, supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

    Related Conference of Antibiotics: Market Analysis & Business Opportunities

    April 10-11, 2020

    Polymer Catalysis 2020

    Valencia, Japan
    April 27-28, 2020

    5th World Conference on Applied Microbiology and Beneficial Microbes

    Singapore City, Singapore
    April 27-28, 2020

    25th World Congress on Biotechnology

    Amsterdam, Netherlands
    May 10-11, 2020

    Biostatistics Meet 2020

    Rome, Brazil
    June 09-10, 2020

    4th International Conference on Medical & Clinical Microbiology

    Singapore City, Singapore
    June 15-16, 2020

    49th World Congress on Microbiology

    London, UK
    June 15-16, 2020

    Cell Tissue Science 2020

    Valencia, Spain
    June 24-25, 2020

    12th International Virology Summit

    Rome, Italy
    July 27-28, 2020

    28th World Summit on Genetics and Genomics

    Madrid, Spain
    August 26-27, 2020

    13thAnnual Meet on Bacteriology & Applied Microbiology

    Singapore City, Singapore
    September 02-03, 2020

    5th International Conference on Bacteriology

    Barcelona, Spain
    September 17-18, 2020

    3rd World Congress on Virology and Diseases Control

    Vienna, Austria
    September 18-19, 2020

    2nd International Conference on Cell Metabolism

    Dubai, UAE
    September 21-22, 2020

    12th Global Summit on Immunology and Cell Biology

    Valencia, Spain
    September 25-26, 2020

    Annual Congress on Clinical Microbiology and Yeast Congress

    Vancouver, Canada
    September 28-29, 2020

    8th World Congress and Expo on Applied Microbiology

    Barcelona, Spain
    October 06-07, 2020

    6th World Summit on Dental Health and Oral Hygiene

    Milan, Italy
    November 11-12, 2020

    International Conference on Applied Microbiology

    Tokyo, Japan
    November 11-12, 2020

    International Conference on Microbiology

    Tokyo, Japan
    December 03-04, 2020

    3rd World Pediatric Infectious Disease Congress

    Singapore City, Singapore
    December 07-08, 2020

    International Conference on Molecular Microbiology

    Dubai, UAE

    Antibiotics: Market Analysis & Business Opportunities Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in